Targeting pathogenic Th17 cells

How two new autoimmune targets drive pathogenic Th17 activity

A recent pair of studies offers two new approaches to treating autoimmune diseases that go after the source of Th17-mediated inflammation.

T helper type 17 (Th17) cells are effector T cells

Read the full 315 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE